Equipoise in pediatric acute liver failure
- PMID: 38409886
- DOI: 10.1002/jpn3.12166
Equipoise in pediatric acute liver failure
Keywords: corticosteroids; immune dysregulation; immunosuppression; liver transplantation.
References
REFERENCES
-
- Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317:141‐145.
-
- Squires, Jr. RH, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652‐658.
-
- Molina RA, Katzir L, Rhee C, et al. Early evidence of bone marrow dysfunction in children with indeterminate fulminant hepatic failure who ultimately develop aplastic anemia. Am J Transplant. 2004;4:1656‐1661.
-
- Chapin CA, Melin‐Aldana H, Kreiger PA, et al. Activated CD8 t‐cell hepatitis in children with indeterminate acute liver failure: results from a multicenter cohort. J Pediatr Gastroenterol Nutr. 2020;71:713‐719.
-
- Leonis MA, Miethke AG, Fei L, et al. Four biomarkers linked to activation of cluster of differentiation 8‐positive lymphocytes predict clinical outcomes in pediatric acute liver failure. Hepatology. 2021;73:233‐246.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources